Not so urgent afterall

Quote

Anonymous

Guest
Merck is desperate. This urgent call to action around Simva 80 and/or Vytorin 10/80 is silly. Sure, it is important and we can talk about the change with customers, but this fire drill is a little much.

Look at your data and see how many of your customers even use 80 and/or 10/80. Even then, we can assume many of those are tablet splitting scripts.

Check the box is back!
 






Anonymous said:
Merck is desperate. This urgent call to action around Simva 80 and/or Vytorin 10/80 is silly. Sure, it is important and we can talk about the change with customers, but this fire drill is a little much.

Look at your data and see how many of your customers even use 80 and/or 10/80. Even then, we can assume many of those are tablet splitting scripts.

Check the box is back!
Click to expand...

We are so pitiful and are drowning in pathetic management. This being another fine example of that fact imho.
 


















Made two calls before the teleconference was announced, then had to get out of field. Not a bad way to get a day off. The next "5" days will suck if you have a micromanager like mine. He loves these types of things because they are tangible signs that all his reps suck and can't even get to "all of our customers and deliver a message."
 






"This will add to our reliable presence..."

Great, it will also decrease our profits. Oh, wait, thats right, I forgot! This is all for the patient! Well then, lower the price assburps

What a freaking joke
Fire all HQ marketing people immediately
 






How did we ever get to this? Who would have ever thought that 20+ years later, we would have a bunch of asswipes sitting around a table in our marketing department with idea of:

Hey, lets use this negative information as a way to increase our trust and value to doctors!

How sad it has all become. Just doing time till time runs out-on all of us
 






Anonymous said:
How did we ever get to this? Who would have ever thought that 20+ years later, we would have a bunch of asswipes sitting around a table in our marketing department with idea of:

Hey, lets use this negative information as a way to increase our trust and value to doctors!

How sad it has all become. Just doing time till time runs out-on all of us
Click to expand...

lol!! Well stated post #7. Who really believes this will improve trust and value with customers?! If anything, if I were a HCP, I wouldn't trust any pharma company. I don't blame doctors who wait a few years before trying a new product let alone an old compound like simvi.. This fire drill is counter-productive at best in mine eyes. Now, I have to listen to my DCO spew more sh**t about what we just heard. A wasted day in the field and for the next 2-5 days to do what Mother Merck wants us to do. IT IS TIME TO MAKE PLANS TO LEAVE THE INDUSTRY! TOO MUCH IS TOO MUCH!
 






And to get Port 1 involved! Like we don't have enough to do with "Dulerious" and other products. Yeah, I can really see myself putting everything else aside to jump on this "fire". What a pathetic company.
 






Look at it as a legal reason to communicate the info to customers. Then use it as an excuse to hopefully see the doc even though we know hardly anyone prescribe that dose. Stop whining. This should give you an excuse to be busy for a few days. Soon some of us will be laid off.
 












Kind of a joke. We kind of knew about that with Zocor 80 mg. Every doc in town knows that about high-dose statins. We shelved the plan to introduce Zocor 160 mg because of that. This change simply made it official.
 






Anonymous said:
Kind of a joke. We kind of knew about that with Zocor 80 mg. Every doc in town knows that about high-dose statins. We shelved the plan to introduce Zocor 160 mg because of that. This change simply made it official.
Click to expand...

Merck is planning to launch a combination of Zocor 160 and Saphris 10mg. That way, the schizophrenics will be too sleepy and too sore to fight when the straight-jacket is applied.

Some Stepford in marketing will get a promotion for it.
 












Anonymous said:
This is how desperate things have become to give people "work" and justify jobs. Such a sad tale.
Click to expand...

If you are a current Merck rep...you can see it as a glass half full and said you have something to say "new" for awhile. We cannot be choosy when there is nothing coming out of R&D. It may be busy work or a silly way to justify a job or sad. Would you be willing to give up your paycheck then?
 






Anonymous said:
Merck is desperate. This urgent call to action around Simva 80 and/or Vytorin 10/80 is silly. Sure, it is important and we can talk about the change with customers, but this fire drill is a little much.

Look at your data and see how many of your customers even use 80 and/or 10/80. Even then, we can assume many of those are tablet splitting scripts.

Check the box is back!
Click to expand...

Lawyers run this company starting with Kenny and still shaking from Vioxx.
 












Anonymous said:
How did we ever get to this? Who would have ever thought that 20+ years later, we would have a bunch of asswipes sitting around a table in our marketing department with idea of:

Hey, lets use this negative information as a way to increase our trust and value to doctors!

How sad it has all become. Just doing time till time runs out-on all of us
Click to expand...

I spend hours and hours to get one appointment and my calendar fills a month in advance. I don't even carry this product and could not agree more with the above statement. I listened and can certainly see the need to let all of our pharmacist/hospitals and clinics know. But a one/one F2F selling opportunity for Zetia, are you fricking kidding me? I nearly threw up in my mouth. "Doctor, so if you're concerned about getting your patients to goal now that 80 mg Z/s could cause Rhabdo, just use the 40 and add Zetia or write V." WTF? That is how this firedrill is going to sound. If I said anything even politely close, it would totally look desperate and ruin my credibility, or what's left of it.
 


















Top Bottom
Back
Quote